Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P., Chaisuksant S., Pilaikul J., Thinkhamrop B., Phiphitaporn S., Susaengrat W., Toondee C., Wongrattanacheewin S., Wuthiekanun V., Chantratita N., Thaipadungpanit J., Day NP., Limmathurotsakul D., Peacock SJ.

DOI

10.1016/s0140-6736(13)61951-0

Type

Journal article

Journal

The Lancet

Publisher

Elsevier BV

Publication Date

03/2014

Volume

383

Pages

807 - 814

Permalink Original publication